マレーシア政府　TPP協定最終文書（英文）を公表

　マレーシア政府　米国政府　TPP協定最終文書（英文）を公表

マレーシア政府が来年の議会審議に備え、また米国政府も、TPP協定の”final text”全文（英文）を公表した。この膨大なテキストの読み解きは専門家でも多大な時間と労力を要するだろう。英文だから、日本人には一層難しい。日本政府も公表したと言うが、中身は「全章概要」に過ぎない。

　例えば「現代のバイオテクノロジーによる生産品の貿易」について英文は、次のように定めるが、

1. The Parties confirm the importance of transparency, cooperation and exchanging information related to the trade of products of modern biotechnology.

2. Nothing in this Article shall prevent a Party from adopting measures in accordance with its rights and obligations under the WTO Agreements or other provisions of this Agreement.

3. Nothing in this Article shall require a Party to adopt or modify its laws, regulations, and policies for the control of products of modern biotechnology within its territory.

4. When available and subject to its laws, regulations and policies, each Party shall make available publicly:

(a) any documentation requirements for completing an application for the authorization of a product of modern biotechnology;

(b) a summary of any risk or safety assessment that has led to the authorization of a product of modern biotechnology; and

5. Each Party shall identify contact point(s) for the sharing of information on issues related to low level presence (LLP)¹³. occurrences

6. In order to address an LLP occurrence, and with a view to preventing a future LLP occurrence, at the request of an importing Party, an exporting Party shall, where available and subject to its laws, regulations and policies:

(a) provide a summary of the risk or safety assessment or assessments, if any, that the exporting party conducted in connection with an authorization of a specific plant product of modern biotechnology;

(b) provide, if known to the exporting Party, contact information for any entity within its territory that received authorization for the plant product of modern biotechnology and whom the Party believes is likely to possess:

(i) any existing, validated methods for the detection of the plant product of modern biotechnology found at a low level in a shipment;

(ii) any reference sample necessary for the detection of the LLP occurrence; and

(iii) relevant information that can be used by the importing Party to conduct a risk or safety assessment or, if a food safety assessment is appropriate, relevant information for a food safety assessment in accordance with Annex 3 of the Codex Guideline for the conduct of Food Safety Assessment of Foods Derived from Recombinant-DNA Plants (CAC/GL 45-2003);and

7. In the event of an LLP occurrence, the importing Party shall, subject to its laws, regulations and policies:

(a) inform the importer or the importer’s agent of the LLP occurrence and of any additional information which the importer will be required to submit to allow the importing Party to make a decision on the disposition of the shipment in which the LLP occurrence has been found;

(b) when available, provide to the exporting Party a summary of any risk or safety assessment that the importing Party has conducted in connection with the LLP occurrence;

(c) ensure that the measures¹⁴applied to address the LLP occurrence are appropriate to achieve compliance with its domestic laws, regulations and policies.

(a) each exporting party shall consistent with its domestic laws, regulations, and policies endeavor to encourage technology developers to submit applications to Parties for authorization of plants and plant products of modern biotechnology; and

(b) a Party authorizing plant and plant products derived from modern biotechnology shall endeavor to:

(i) allow year-round submission and review of applications for authorization of plants and plant products of modern biotechnology; and

(ii) increase communications among and between the Parties regarding new authorizations of plants and plant products of modern biotechnology so as to improve global information exchange.

9. The Parties hereby establish a working group on products of modern biotechnology under the Committee on Agricultural Trade (Working Group) for information exchange and cooperation on trade-related matters associated with products of modern biotechnology. The Working Group shall be comprised of representatives of all Parties that, in writing, inform the Committee on Agricultural Trade that they will participate in the Working Group and name one or more representatives to the Working Group.

(a) exchange, subject to a Party’s laws, regulations and policies, information on issues, including on existing and proposed domestic laws, regulations and policies related to the trade of products of modern biotechnology; and

(b) further enhance cooperation among two or more Parties, where there is mutual interest related to the trade of products of modern biotechnology.

11. The Woring Group may meet in person, or by any other means as mutually determined by the Parties who have named representatives to the Working Group.

　「締約国の法令及び政策の採用又は修正を求めるものではない旨規定した上で、現代のバイオテクノロジーによる生産品（遺伝子組換え作物）の承認に際しての透明性（承認のための申請に必要な書類の要件、危険性又は安全性の評価の概要及び承認された産品の一覧表の公表）、未承認の遺伝子組換え作物が微量に混入された事案についての情報の共有（輸入締約国の要請に基づき輸出締約国において現代のバイオテクノロジーによる生産品につき承認を受けた企業に対し情報の共有を奨励する規定を含む。）、情報交換のための作業部会の設置等について規定」。これでは条文の正体を見極めるのは難しい。ほとんど騙しではないか。何か隠しているのではないか、疑心暗鬼が募るだけだろう。

　英語圏の国と日本では大変な情報格差がある。野党だけでなく、農協も与党も、正体不明なTPPへの対策を要求する前に、一刻も早い日本語版テキストの公表を要求すべきである。公表できないような協定からは、ただちに撤退すべきである。

　公表された協定文及び付属文書は次のリンクからダウンロードできる。